Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0424605 (
developmental delay
)
8,158
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Leukoencephalopathy with calcifications and cysts (LCC) is a triad of neuroradiological symptoms characteristic of Labrune syndrome, which was first described in 1996. For 20 years, the diagnosis was only based on clinical, neuroradiological and histopathological findings. Differential diagnosis included a wide spectrum of diseases. Finally, in 2016, genetic mutation in the
SNORD118
gene was confirmed to cause Labrune syndrome. The authors describe a case of a teenage girl with progressive headaches, without
developmental delay
, presenting with calcifications and white matter abnormality in neuroimaging. Follow-up studies showed the progression of leukoencephalopathy and cyst formation. The first symptoms and initial imaging results posed diagnostic challenges. The final diagnosis was established based on genetic results. The authors discuss the possible therapy of LCC with
Bevacizumab
.
...
PMID:Leukoencephalopathy with Calcifications and Cysts-The First Polish Patient with Labrune Syndrome. 3321 75